We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 25.25
Bid: 25.00
Ask: 25.50
Change: -2.00 (-7.34%)
Spread: 0.50 (2.00%)
Open: 26.75
High: 26.75
Low: 25.25
Prev. Close: 27.25
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: New MaxCyte chair buys USD220,000 in shares

Tue, 23rd Nov 2021 16:21

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and not separately reported by Alliance News:

----------

MaxCyte Inc - Maryland-based platform for cell-based research - Richard Douglas, who was promoted to chair earlier this month, buys 20,000 shares at average USD11.12, worth USD222,480, on Monday. The purchase on Nasdaq in New York is his only share holding, though he also has 131,600 stock options.

----------

Harbour Energy PLC - North Sea-focused oil and gas - Non-Executive Director Anne Stevens buys 30,000 shares at average 400.05p, worth GBP120,016, on Monday. The purchase is her only holding.

----------

James Cropper PLC - paper products manufacturer based in Cumbria - Chair Mark Cropper buys 3,700 shares at GBP15.00, worth GBP55,500, on Friday last week. The shares were bought from two members of the Cropper family, which are part of the concert party, so his beneficial shareholding remains unchanged at 1.9 million shares, a 19% stake. The total interest of the concert party is 3.6 million shares, a 38% stake.

----------

Ryanair Holdings PLC - Dublin-based airline - Non-Executive Director Geoff Doherty buys 3,000 shares at EUR15.84, worth EUR47,505, on Friday last week in Dublin.

----------

Anglo Asian Mining PLC - gold, copper and silver producer in Azerbaijan - Non-Executive Director John Monhemius buys 25,000 shares at 112.90p, worth GBP28,225, on Tuesday. Monhemius now has 366,890 shares, a 0.3% stake.

----------

Sareum Holdings PLC - Cambridge, England-based drug developer for cancer and autoimmune diseases - Non-Executive Chair Stephen Parker buys 277,777 shares at 3.6p, worth GBP10,000, on Tuesday.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Aug 2020 12:36

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

Read more
24 Jul 2020 13:56

UK TRADING UPDATE SUMMARY: Naked Wines Chair Leaves, Online Sales Grow

UK TRADING UPDATE SUMMARY: Naked Wines Chair Leaves, Online Sales Grow

Read more
3 Jun 2020 18:09

Sareum Raises GBP1 Million For TYK2/JAK1 Research Programmes

Sareum Raises GBP1 Million For TYK2/JAK1 Research Programmes

Read more
3 Jun 2020 10:56

UK WINNERS & LOSERS SUMMARY: M&S Gains, B&M Loses On Jefferies Ratings

UK WINNERS & LOSERS SUMMARY: M&S Gains, B&M Loses On Jefferies Ratings

Read more
2 Jun 2020 17:46

Sareum Looks To Raise Cash For TYK2/JAK1 Research Programmes

Sareum Looks To Raise Cash For TYK2/JAK1 Research Programmes

Read more
26 Mar 2020 11:46

Sareum Loss Narrows; Could Secure GBP900,000 From China License Deal

Sareum Loss Narrows; Could Secure GBP900,000 From China License Deal

Read more
17 Dec 2019 13:20

Sareum Holdings Happy With Progress Despite Mixed Year

Sareum Holdings Happy With Progress Despite Mixed Year

Read more
17 Dec 2019 11:55

Sareum Expects Possible Significant Delay To Sierra Milestone Payments

Sareum Expects Possible Significant Delay To Sierra Milestone Payments

Read more
10 Dec 2019 15:57

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
15 Oct 2019 11:43

Sareum Narrows Annual Loss As Immunotherapy Programmes Progress

Sareum Narrows Annual Loss As Immunotherapy Programmes Progress

Read more
27 Sep 2019 09:20

Sareum's SAR-20351 Inhibitor Reduces Tumour Growth In Various Cancers

Sareum's SAR-20351 Inhibitor Reduces Tumour Growth In Various Cancers

Read more
27 Sep 2019 09:10

Sareum Holdings upbeat ahead of cancer research presentation

(Sharecast News) - Specialist small molecule drug development company Sareum Holdings announced on Friday that it will present new preclinical data from its 'SDC-1802 TYK2/JAK1' inhibitor cancer research programme at the American Association for Cancer Research (AACR) National Cancer Institute (NCI) European Organisation for Research and Treatment of Cancer (EORTC) international conference, in late October in Boston, Massachusetts.

Read more
27 Aug 2019 13:24

Sareum Optimistic On Cancer Treatment As Partner Changes Focus

(Alliance News) - Small molecule drug developer Sareum Holdings PLC on Tuesday said investee Sierra Oncology will need to look at new options to progress development of a key drug.Sierra to

Read more
27 Aug 2019 08:35

Sareum Holdings expects broadly flat interim losses

(Sharecast News) - Drug developer Sareum expects interim losses to be broadly flat year-on-year as it continues to focus on the development of multiple treatments for cancer and autoimmune diseases.

Read more
25 Jun 2019 18:33

Sareum Raises GBP513,000 Through Discounted Placing For Pipeline Push

(Alliance News) - Sareum Holdings PLC said Tuesday it raised GBP513,000 through a discounted share placing by Hybridan LLP, whilst also opening the offer to retail investors through drug firm at ,

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.